NASDAQ
No price data available for this timeframe.
Globus Medical, Inc. (GMED) has a price/fcf ratio of 20.04x as of Monday, May 25, 2026. This represents a 52.50% decrease compared to its 12-month average of 42.20x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.